Taysha gene therapies announces positive recommendation from independent data monitoring committee of reveal phase 1/2 trial in rett syndrome

Independent data monitoring committee recommended reveal phase 1/2 trial continuation and proceeding with dosing of second patient based on encouraging initial clinical data from the first adult with rett syndrome dosed with investigational gene therapy tsha-102
TSHA Ratings Summary
TSHA Quant Ranking